companydata.dkcompanydata.dk

MACURE PHARMA ApS: Financial statements 2020

CVR: 35234748

Source: annual report 2020, Danish Business Authority

01/01/202031/12/2020

MACURE PHARMA ApS (CVR 35234748) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 15,148,594 and a net result of DKK 5,257,622 compared with DKK 9,187,713 the year before. That is a decrease of 7.2% compared with the year before. Equity in the 2020 report amounted to DKK 10,452,015. The solvency ratio was 18.2%. The company had 10 employees in the financial year.

Gross Profit
DKK 15,148,594
Profit/Loss
DKK 5,257,622
Equity
DKK 10,452,015
Total Assets
DKK 57,551,604
Employees
10

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-15.1 mio.5.3 mio.10.5 mio.10
2019-16.3 mio.9.2 mio.14.2 mio.6
2018-10.3 mio.5.3 mio.10.5 mio.5
2017-14.4 mio.8.9 mio.12 mio.4
2016-13.3 mio.9.1 mio.5.5 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is MACURE PHARMA ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

MACURE PHARMA ApS: The 2019 annual report is outJul 8, 2020

MACURE PHARMA ApS has published its annual report for 2019. Gross profit came to DKK 16,325,244, and the net result was DKK 9,187,713.

About MACURE PHARMA ApS

MACURE PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2013. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Mads Renlef Henningsen and Lars Mark Poulsen. The company is owned by Nest Egg ApS. The company has 3 employees (2018). In 2025, the company reported a gross profit of DKK 47,649,382 and a net result of DKK 11,054,004 compared with DKK 8,495,013 the year before. Equity in the 2025 report amounted to DKK 18,033,649.

Source: annual report 2025, Danish Business Authority